LCM
MDGL icon

Lucas Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Lucas Capital Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-603
Closed -$37K – 125
2015
Q3 		$37K Hold
603
– – 0.02% 121
2015
Q2 		$47K Hold
603
– – 0.02% 131
2015
Q1 		$41K Hold
603
– – 0.02% 129
2014
Q4 		$56K Buy
603
+29
+5% +$3K 0.02% 133
2014
Q3 		$61K Buy
574
+14
+3% +$1.95K 0.02% 142
2014
Q2 		$80K Buy
560
+29
+5% +$4.24K 0.03% 148
2014
Q1 		$80K Hold
531
– – 0.03% 136
2013
Q4 		$97K Buy
+531
New +$97.2K 0.03% 139

Other funds holding MDGL

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Lucas Capital Management's MDGL Position: Q4 2015 in Review

Lucas Capital Management sold out of Madrigal Pharmaceuticals (MDGL) in Q4 2015, closing a stake of 603 shares — an estimated $37K sold.

Lucas Capital Management first reported a position in MDGL in Q4 2013 and held it in 8 quarters. The position peaked at $97K in Q4 2013. 75 funds tracked by Wall St. Rank hold MDGL as of Q4 2015.

  • Lucas Capital Management reported no remaining Madrigal Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Lucas Capital Management sold 603 Madrigal Pharmaceuticals shares in Q4 2015, an estimated $37K.
  • Lucas Capital Management first reported a position in Madrigal Pharmaceuticals in Q4 2013 and held it in 8 quarters.
  • Lucas Capital Management's Madrigal Pharmaceuticals position peaked at $97K in Q4 2013.
  • 75 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q4 2015.

Based on Lucas Capital Management's 13F filing for Q4 2015, filed 25 Jan 2016.